Helpful, thanks. Always good to remind oneself of the risks in drug development and the importance of large, robust trials to confirm or reject potential signal. 2-73 is promising, but the jury is still out on its viability. Fingers crossed. We have a great shot.
Market Data 
Markets 
AI
